# DECOR Information for Project: CDA-CH-EMED eMedication (cdachemed-)
Release 1.0.3.3 as of 2026‑02‑09 15:04:46 | | | HTML built on 2026‑02‑09 15:20:20

- Front Page
- Project Information
- Dataset
- Scenarios
- Identifiers
- Terminology
- Templates
- Issues
- Compile Time
- Legal

## Identifiers

As for now used for rendering purposes only.

### EDQM 0.4.0.127.0.16.1.1.2.1

Language | Display Name | Description
--- | --- | ---
en-US | EDQM | EDQM

### ISO 3166 Part 1 Country Codes 1.0.3166.1

Language | Display Name | Description
--- | --- | ---
en-US | ISO 3166 Part 1 Country Codes | ISO 3166 Part 1 Country Codes

### SNOMED Clinical Terms Swiss Extension 2.16.756.5.30.1.127.3.4

Language | Display Name | Description
--- | --- | ---
en-US | SNOMED Clinical Terms Swiss Extension | SNOMED Clinical Terms Swiss Extension

### EventTiming 2.16.840.1.113883.4.642.4.76

Language | Display Name | Description
--- | --- | ---
en-US | EventTiming | EventTiming

### AdministrativeGender 2.16.840.1.113883.5.1

Language | Display Name | Description
--- | --- | ---
en-US | AdministrativeGender | AdministrativeGender

### ActMood 2.16.840.1.113883.5.1001

Language | Display Name | Description
--- | --- | ---
en-US | ActMood | ActMood

### HL7ActRelationshipType 2.16.840.1.113883.5.1002

Language | Display Name | Description
--- | --- | ---
en-US | HL7ActRelationshipType | HL7ActRelationshipType

### Entity Code 2.16.840.1.113883.5.1060

Language | Display Name | Description
--- | --- | ---
en-US | Entity Code | Entity Code

### Observation Value 2.16.840.1.113883.5.1063

Language | Display Name | Description
--- | --- | ---
en-US | Observation Value | Observation Value

### Participation Mode 2.16.840.1.113883.5.1064

Language | Display Name | Description
--- | --- | ---
en-US | Participation Mode | Participation Mode

### RoleStatus 2.16.840.1.113883.5.1068

Language | Display Name | Description
--- | --- | ---
en-US | RoleStatus | RoleStatus

### Substance Admin Substitution 2.16.840.1.113883.5.1070

Language | Display Name | Description
--- | --- | ---
en-US | Substance Admin Substitution | Substance Admin Substitution

### RoleClass 2.16.840.1.113883.5.110

Language | Display Name | Description
--- | --- | ---
en-US | RoleClass | RoleClass

### RoleCode 2.16.840.1.113883.5.111

Language | Display Name | Description
--- | --- | ---
en-US | RoleCode | RoleCode

### Route Of Administration 2.16.840.1.113883.5.112

Language | Display Name | Description
--- | --- | ---
en-US | Route Of Administration | Route Of Administration

### SpecimenType 2.16.840.1.113883.5.129

Language | Display Name | Description
--- | --- | ---
en-US | SpecimenType | SpecimenType

### TargetAwareness 2.16.840.1.113883.5.137

Language | Display Name | Description
--- | --- | ---
en-US | TargetAwareness | TargetAwareness

### TimingEvent 2.16.840.1.113883.5.139

Language | Display Name | Description
--- | --- | ---
en-US | TimingEvent | TimingEvent

### ActStatus 2.16.840.1.113883.5.14

Language | Display Name | Description
--- | --- | ---
en-US | ActStatus | ActStatus

### MaritalStatus 2.16.840.1.113883.5.2

Language | Display Name | Description
--- | --- | ---
en-US | MaritalStatus | MaritalStatus

### BasicConfidentialityKind 2.16.840.1.113883.5.25

Language | Display Name | Description
--- | --- | ---
en-US | BasicConfidentialityKind | BasicConfidentialityKind

### Act Code 2.16.840.1.113883.5.4

Language | Display Name | Description
--- | --- | ---
en-US | Act Code | Act Code

### HL7ActClass 2.16.840.1.113883.5.6

Language | Display Name | Description
--- | --- | ---
en-US | HL7ActClass | HL7ActClass

### LanguageAbilityMode 2.16.840.1.113883.5.60

Language | Display Name | Description
--- | --- | ---
en-US | LanguageAbilityMode | LanguageAbilityMode

### LanguageAbilityProficiency 2.16.840.1.113883.5.61

Language | Display Name | Description
--- | --- | ---
en-US | LanguageAbilityProficiency | LanguageAbilityProficiency

### ActPriority 2.16.840.1.113883.5.7

Language | Display Name | Description
--- | --- | ---
en-US | ActPriority | ActPriority

### IANA Media Type 2.16.840.1.113883.5.79

Language | Display Name | Description
--- | --- | ---
en-US | IANA Media Type | IANA Media Type

### Observation Interpretation 2.16.840.1.113883.5.83

Language | Display Name | Description
--- | --- | ---
en-US | Observation Interpretation | Observation Interpretation

### Observation Method 2.16.840.1.113883.5.84

Language | Display Name | Description
--- | --- | ---
en-US | Observation Method | Observation Method

### orderableDrugForm 2.16.840.1.113883.5.85

Language | Display Name | Description
--- | --- | ---
en-US | orderableDrugForm | orderableDrugForm

### Participation Function 2.16.840.1.113883.5.88

Language | Display Name | Description
--- | --- | ---
en-US | Participation Function | Participation Function

### Participation Signature 2.16.840.1.113883.5.89

Language | Display Name | Description
--- | --- | ---
en-US | Participation Signature | Participation Signature

### ParticipationType 2.16.840.1.113883.5.90

Language | Display Name | Description
--- | --- | ---
en-US | ParticipationType | ParticipationType

### LOINC 2.16.840.1.113883.6.1

Language | Display Name | Description
--- | --- | ---
en-US | LOINC | LOINC

### Language 2.16.840.1.113883.6.121

Language | Display Name | Description
--- | --- | ---
en-US | Language | Language

### WHO Anatomical Therapeutic Chemical classification 2.16.840.1.113883.6.73

Language | Display Name | Description
--- | --- | ---
en-US | WHO Anatomical Therapeutic Chemical classification | WHO Anatomical Therapeutic Chemical classification

### UCUM 2.16.840.1.113883.6.8

Language | Display Name | Description
--- | --- | ---
en-US | UCUM | UCUM

### SNOMED Clinical Terms 2.16.840.1.113883.6.96

Language | Display Name | Description
--- | --- | ---
en-US | SNOMED Clinical Terms | SNOMED Clinical Terms

## List of Template Identifiers used in this project

Id | Display Name | Effective date | Type
--- | --- | --- | ---
1.3.6.1.4.1.19376.1.5.3.1.4.1 | IHE Severity Entry | 2016‑11‑12 | cdaentrylevel
1.3.6.1.4.1.19376.1.5.3.1.4.1.1 | IHE Problem Status Observation | 2013‑12‑20 | cdaentrylevel
1.3.6.1.4.1.19376.1.5.3.1.4.1.2 | IHE Health Status Observation | 2013‑12‑20 | cdaentrylevel
1.3.6.1.4.1.19376.1.5.3.1.4.2 | IHE Comment Entry | 2016‑11‑12 | cdaentrylevel
1.3.6.1.4.1.19376.1.5.3.1.4.3 | IHE Patient Medication Instructions | 2019‑10‑16 16:01:48 | cdaentrylevel
1.3.6.1.4.1.19376.1.5.3.1.4.3.1 | Fulfillment Instructions | 2019‑10‑16 16:01:48 | cdaentrylevel
1.3.6.1.4.1.19376.1.5.3.1.4.4.1 | IHE Internal Reference Entry | 2019‑10‑16 16:12:02 | cdaentrylevel
1.3.6.1.4.1.19376.1.5.3.1.4.5 | IHE Problem Entry | 2016‑11‑12 | cdaentrylevel
1.3.6.1.4.1.19376.1.5.3.1.4.6 | IHE Allergies And Intolerances Entry | 2016‑11‑12 | cdaentrylevel
1.3.6.1.4.1.19376.1.9.1.1.1 | IHE Community Prescription Content Module | 2018‑01‑17 16:46:48 | cdadocumentlevel
1.3.6.1.4.1.19376.1.9.1.1.2 | IHE Pharmacy Pharmaceutical Advice Document Content Module | 2019‑10‑16 16:42:19 | cdadocumentlevel
1.3.6.1.4.1.19376.1.9.1.1.3 | IHE Pharmacy Dispense Document Content Module | 2019‑10‑16 16:41:16 | cdadocumentlevel
1.3.6.1.4.1.19376.1.9.1.1.5 | IHE Pharmacy Medication List | 2018‑01‑17 18:06:02 | cdadocumentlevel
1.3.6.1.4.1.19376.1.9.1.1.6 | IHE Medication Treatment Plan Document Content Module | 2019‑10‑16 16:37:16 | cdadocumentlevel
1.3.6.1.4.1.19376.1.9.1.2.1 | IHE Prescription Section Content Module | 2018‑01‑10 11:13:04 | cdasectionlevel
1.3.6.1.4.1.19376.1.9.1.2.2 | IHE Pharmaceutical Advice Section Content Moudule | 2018‑01‑10 11:13:04 | cdasectionlevel
1.3.6.1.4.1.19376.1.9.1.2.3 | IHE Dispense Section Content Module | 2018‑01‑10 11:13:04 | cdasectionlevel
1.3.6.1.4.1.19376.1.9.1.2.5 | IHE Medication List Section Content Module | 2018‑01‑10 08:39:19 | cdasectionlevel
1.3.6.1.4.1.19376.1.9.1.2.6 | IHE Medication Treatment Plan Section Content Module | 2017‑04‑03 07:47:01 | cdasectionlevel
1.3.6.1.4.1.19376.1.9.1.3.1 | IHE MedicineEntryContentModule | 2019‑08‑27 16:13:43 | cdaentrylevel
1.3.6.1.4.1.19376.1.9.1.3.10 | IHE MTP Reference Entry Content Module | 2022‑02‑23 10:03:10 | cdaentrylevel
1.3.6.1.4.1.19376.1.9.1.3.11 | IHE PRE Reference Entry Content Module | 2017‑01‑11 11:10:04 | cdaentrylevel
1.3.6.1.4.1.19376.1.9.1.3.12 | IHE DIS Reference Entry Content Module | 2017‑01‑11 12:32:40 | cdaentrylevel
1.3.6.1.4.1.19376.1.9.1.3.13 | IHE PADV Reference Entry Content Module | 2017‑10‑11 12:06:00 | cdaentrylevel
1.3.6.1.4.1.19376.1.9.1.3.15 | IHE Renewal Period Content Module | 2018‑01‑11 15:34:25 | cdaentrylevel
1.3.6.1.4.1.19376.1.9.1.3.16 | IHE Validation Step Entry Content Module | 2020‑02‑03 18:26:16 | cdaentrylevel
1.3.6.1.4.1.19376.1.9.1.3.2 | IHE Prescription Item Entry Content Module | 2022‑02‑24 11:17:42 | cdaentrylevel
1.3.6.1.4.1.19376.1.9.1.3.3 | IHE Pharmaceutical Advice Item Entry Content Module | 2022‑06‑30 14:58:28 | cdaentrylevel
1.3.6.1.4.1.19376.1.9.1.3.4 | IHE Dispense Item Entry Content Module | 2022‑02‑17 13:16:06 | cdaentrylevel
1.3.6.1.4.1.19376.1.9.1.3.7 | IHE Medication Treatment Plan Item Entry Content Module | 2022‑02‑24 11:14:07 | cdaentrylevel
1.3.6.1.4.1.19376.1.9.1.3.9.1 | IHE Substitution Permission Content Module | 2018‑01‑10 15:34:25 | cdaentrylevel
1.3.6.1.4.1.19376.1.9.1.3.9.2 | IHE Substitution Act Content Module | 2018‑01‑10 15:34:25 | cdaentrylevel
chdachpharm-template-document-13 | Medication List document | 2018‑01‑22 15:17:26 | cdadocumentlevel
chdachpharm-template-document-3 | Medication Card document | 2016‑05‑13 | cdadocumentlevel
chdachpharm-template-document-4 | Medication Prescription document | 2016‑05‑21 | cdadocumentlevel
chdachpharm-template-document-5 | Medication Dispense document | 2016‑05‑21 | cdadocumentlevel
chdachpharm-template-document-6 | Pharmaceutical Advice document | 2016‑05‑21 | cdadocumentlevel
chdachpharm-template-document-7 | Medication Treatment Plan document | 2017‑04‑12 13:57:31 | cdadocumentlevel
chdachpharm-template-document-9 | CDA-CH v2.1 - structuredBody | 2019‑10‑17 15:22:41 | cdadocumentlevel
chdachpharm-template-document- | Medication In Reserve Entry Content Module | 2022‑02‑24 09:27:22 | cdaentrylevel
chdachpharm-template-header-1 | Patient - recordTarget | 2022‑06‑21 13:45:28 | cdaheaderlevel
chdachpharm-template-header-13 | Document Replacement - relatedDocument | 2019‑01‑01 21:22:58 | cdaheaderlevel
chdachpharm-template-header-14 | Insurance Card - participant | 2018‑04‑18 | cdaheaderlevel
chdachpharm-template-header-15 | Insurance - participant | 2018‑04‑18 | cdaheaderlevel
chdachpharm-template-header-16 | Order Reference - inFulfillmentOf | 2018‑04‑18 | cdaheaderlevel
chdachpharm-template-header-18 | Document Template Ids CDA-CH v2.0 - structuredBody | 2019‑10‑17 15:21:50 | cdaheaderlevel
chdachpharm-template-header-19 | Document Confidentiality Code | 2019‑09‑12 14:08:42 | cdaheaderlevel
chdachpharm-template-header-20 | Document Set Id and Version Number | 2018‑04‑18 | cdaheaderlevel
chdachpharm-template-header-22 | Document Language | 2022‑02‑24 10:11:09 | cdaheaderlevel
chdachpharm-template-header-23 | Document Id | 2018‑04‑18 | cdaheaderlevel
chdachpharm-template-header-25 | Document Realm | 2018‑04‑18 | cdaheaderlevel
chdachpharm-template-header-3 | Custodian | 2019‑10‑15 09:26:07 | cdaheaderlevel
chdachpharm-template-header-4 | Recipient - informationRecipient | 2018‑04‑18 | cdaheaderlevel
chdachpharm-template-header-40 | Employer - participant | 2019‑01‑01 21:13:32 | cdaheaderlevel
chdachpharm-template-header-43 | Patient Contact - participant | 2019‑11‑19 11:59:25 | cdaheaderlevel
chdachpharm-template-header-44 | Document Code | 2019‑09‑12 15:24:11 | cdaheaderlevel
chdachpharm-template-header-46 | Health Service - documentationOf | 2019‑01‑01 20:53:33 | cdaheaderlevel
chdachpharm-template-header-5 | Legal Authenticator | 2018‑04‑18 | cdaheaderlevel
chdachpharm-template-header-50 | Document Code Medication List | 2019‑12‑02 14:35:36 2018‑01‑08 15:01:14 | cdaheaderlevel
chdachpharm-template-header-51 | Document Code Medication Dispense | 2020‑02‑03 15:37:40 2018‑01‑08 15:01:14 | cdaheaderlevel
chdachpharm-template-header-52 | Document Code Medication Prescription | 2020‑02‑03 17:22:41 2018‑01‑08 15:34:02 | cdaheaderlevel
chdachpharm-template-header-53 | Document Code Pharmaceutical Advice document | 2020‑02‑03 17:30:14 2018‑01‑08 15:40:41 | cdaheaderlevel
chdachpharm-template-header-54 | Document Code Medication Treatment Plan | 2020‑02‑03 17:29:10 2018‑01‑08 15:45:25 | cdaheaderlevel
chdachpharm-template-header-6 | Authenticator | 2019‑01‑01 20:20:44 | cdaheaderlevel
chdachpharm-template-header-7 | Data Enterer | 2018‑04‑18 | cdaheaderlevel
chdachpharm-template-header-70 | Document Code Medication Card | 2018‑01‑08 15:01:14 | cdaheaderlevel
chdachpharm-template-section-10 | Prescription Section Content Module | 2016‑06‑06 | cdasectionlevel
chdachpharm-template-section-11 | Dispense Section Content Module | 2016‑06‑06 | cdasectionlevel
chdachpharm-template-section-12 | Pharmaceutical Advice Section Content Module | 2016‑06‑06 | cdasectionlevel
chdachpharm-template-section-13 | Medication Treatment Plan Section Content Module | 2017‑05‑01 12:51:36 | cdasectionlevel
chdachpharm-template-section-2 | Remarks Section - coded | 2018‑04‑18 | cdasectionlevel
chdachpharm-template-section-44 | Medication List Section Content Module | 2018‑01‑22 15:40:38 | cdasectionlevel
chdachpharm-template-section-45 | Original Representation Section - coded | 2022‑03‑04 16:02:27 | cdasectionlevel
chdachpharm-template-section-9 | Medication Card Section Content Module | 2022‑03‑04 12:34:31 | cdasectionlevel
chdachpharm-template-entry-2 | Annotation Comments | 2016‑11‑12 | cdaentrylevel
chdachpharm-template-entry-33 | Manufactured Material Entry Content Module | 2019‑12‑11 11:34:24 | cdaentrylevel
chdachpharm-template-entry-34 | Medication Treatment Plan Item Entry Content Module | 2019‑12‑11 11:31:52 | cdaentrylevel
chdachpharm-template-entry-35 | Dosage Instructions Start/Stop, Frequency, Dose | 2019‑08‑27 16:30:05 | notype
chdachpharm-template-entry-36 | Dosage Instructions Related Components | 2017‑01‑23 16:30:55 | notype
chdachpharm-template-entry-37 | Dosage Intake Mode Entry Content Module | 2016‑09‑13 16:06:07 | cdaentrylevel
chdachpharm-template-entry-38 | Prescribed Quantity Entry Content Module | 2016‑06‑13 | cdaentrylevel
chdachpharm-template-entry-39 | Substitution Permission Entry Content Module | 2020‑02‑27 14:34:11 | cdaentrylevel
chdachpharm-template-entry-41 | Treatment Reason Entry Content Module | 2016‑06‑13 | cdaentrylevel
chdachpharm-template-entry-42 | Dispense Item Entry Content Module | 2016‑06‑17 | cdaentrylevel
chdachpharm-template-entry-43 | Prescription Item Entry Content Module | 2019‑09‑11 17:05:49 | cdaentrylevel
chdachpharm-template-entry-44 | Pharmaceutical Advice Item Entry Content Module | 2022‑06‑30 15:10:57 | cdaentrylevel
chdachpharm-template-entry-45 | MTP Reference Entry Content Module | 2022‑02‑23 10:07:46 | cdaentrylevel
chdachpharm-template-entry-46 | DIS Reference Entry Content Module | 2018‑01‑11 20:38:46 | cdaentrylevel
chdachpharm-template-entry-47 | PRE Reference Entry Content Module | 2018‑01‑11 18:31:33 | cdaentrylevel
chdachpharm-template-entry-52 | Dosage Instructions Non Structured Entry Content Module | 2016‑09‑13 15:33:18 | cdaentrylevel
chdachpharm-template-entry-53 | PADV Reference Entry Content Module | 2018‑01‑11 21:10:57 | cdaentrylevel
chdachpharm-template-entry-81 | Pharmaceutical Advice Concern Entry Content Module | 2016‑01‑11 11:13:04 | cdaentrylevel
chdachpharm-template-entry-82 | Annotation Comments | 2021‑06‑10 11:32:29 | cdaentrylevel
chdachpharm-template-entry-83 | Observation Media | 2022‑02‑24 09:56:48 | cdaentrylevel
chdachpharm-template-other-1 | Narrative Text Reference With Content | 2021‑06‑08 15:50:58 |
chdachpharm-template-other-12 | Assigned Entity Compilation with id | 2019‑10‑24 16:41:55 | notype
chdachpharm-template-other-14 | Narrative Text Reference | 2021‑06‑09 08:55:14 | notype
chdachpharm-template-other-21 | Device Compilation with name | 2018‑04‑18 | notype
chdachpharm-template-other-23 | Author | 2019‑09‑12 13:48:28 | notype
chdachpharm-template-other-24 | Organization Compilation with name | 2018‑04‑18 | notype
chdachpharm-template-other-26 | Organization Compilation with GLN, name, addr and telecom | 2018‑04‑18 | notype
chdachpharm-template-other-27 | Organization Compilation with name, addr, telecom | 2018‑04‑18 | notype
chdachpharm-template-other-30 | Organization Compilation with GLN and name | 2018‑04‑18 | notype
chdachpharm-template-other-31 | Performer | 2018‑12‑24 19:51:04 | notype
chdachpharm-template-other-32 | Assigned Entity Compilation with id, name, addr, telecom, person and organization | 2019‑10‑24 16:38:14 | notype
chdachpharm-template-other-33 | Organization Compilation with id, name, addr and telecom | 2018‑04‑18 | notype
chdachpharm-template-other-34 | Person Name Information Compilation - eCH-0011 | 2022‑06‑21 14:05:06 | notype
chdachpharm-template-other-35 | Address Information Compilation - eCH-0010 | 2022‑02‑24 10:06:00 | notype
chdachpharm-template-other-36 | CDA-CH v2.0 Header Template Compilation | 2018‑04‑18 | notype
chdachpharm-template-other-41 | Header Template Compilation Medication Dispense document | 2018‑01‑08 15:56:47 | notype
chdachpharm-template-other-42 | Header Template Compilation Medication Card document | 2019‑10‑17 13:58:45 2018‑01‑08 16:20:12 | notype
chdachpharm-template-other-43 | Header Template Compilation Pharmaceutical Advice document | 2018‑01‑08 16:23:16 | notype
chdachpharm-template-other-44 | Header Template Compilation MedicationTreatmentPlan | 2018‑01‑08 16:26:11 | notype
chdachpharm-template-other-45 | Header Template Compilation Medication Prescription document | 2018‑01‑08 16:28:39 | notype
chdachpharm-template-other-46 | Header Template Compilation Medication List document | 2018‑01‑22 15:29:29 | notype
chdachpharm-template-other-49 | Original Text Reference | 2021‑06‑08 18:41:55 | notype
chdachpharm-template-other-54 | Author Compilation with id, name, addr and telecom | 2020‑04‑28 12:02:52 | notype
2.16.840.1.113883.10.12.102 | CDA author | 2005‑09‑07 | cdaheaderlevel
2.16.840.1.113883.10.12.113 | CDA componentOf | 2005‑09‑07 | cdaheaderlevel
2.16.840.1.113883.10.12.114 | CDA Authorization | 2005‑09‑07 | cdaheaderlevel
2.16.840.1.113883.10.12.151 | CDA Organization | 2005‑09‑07 | cdaheaderlevel cdaentrylevel
2.16.840.1.113883.10.12.152 | CDA Person | 2005‑09‑07 | cdaheaderlevel cdaentrylevel
2.16.840.1.113883.10.12.153 | CDA AssignedEntity | 2005‑09‑07 | cdaheaderlevel cdaentrylevel
2.16.840.1.113883.10.12.154 | CDA Informant | 2005‑09‑07 | cdasectionlevel
2.16.840.1.113883.10.12.201 | CDA Section | 2005‑09‑07 | cdasectionlevel
2.16.840.1.113883.10.12.300 | CDA Clinical Statement | 2005‑09‑07 | cdaentrylevel
2.16.840.1.113883.10.12.301 | CDA Act | 2005‑09‑07 | cdaentrylevel
2.16.840.1.113883.10.12.302 | CDA Encounter | 2005‑09‑07 | cdaentrylevel
2.16.840.1.113883.10.12.303 | CDA Observation | 2005‑09‑07 | cdaentrylevel
2.16.840.1.113883.10.12.304 | CDA ObservationMedia | 2005‑09‑07 | cdaentrylevel
2.16.840.1.113883.10.12.305 | CDA Organizer | 2005‑09‑07 | cdaentrylevel
2.16.840.1.113883.10.12.306 | CDA Procedure | 2005‑09‑07 | cdaentrylevel
2.16.840.1.113883.10.12.307 | CDA RegionOfInterest | 2005‑09‑07 | cdaentrylevel
2.16.840.1.113883.10.12.308 | CDA SubstanceAdministration | 2005‑09‑07 | cdaentrylevel
2.16.840.1.113883.10.12.309 | CDA Supply | 2005‑09‑07 | cdaentrylevel
2.16.840.1.113883.10.12.310 | CDA LabeledDrug | 2005‑09‑07 | cdaentrylevel
2.16.840.1.113883.10.12.311 | CDA Material | 2005‑09‑07 | cdaentrylevel
2.16.840.1.113883.10.12.312 | CDA ManufacturedProduct | 2005‑09‑07 | cdaentrylevel
2.16.840.1.113883.10.12.313 | CDA PlayingEntity | 2005‑09‑07 | cdaentrylevel
2.16.840.1.113883.10.12.315 | CDA Device | 2005‑09‑07 | cdaentrylevel
2.16.840.1.113883.10.12.316 | CDA RelatedEntity | 2005‑09‑07 | cdaentrylevel
2.16.840.1.113883.10.12.317 | CDA Place | 2005‑09‑07 | cdaentrylevel
2.16.840.1.113883.10.12.318 | CDA Author (Body) | 2005‑09‑07 | cdaentrylevel
2.16.840.1.113883.10.12.319 | CDA Informant (Body) | 2005‑09‑07 | cdaentrylevel
2.16.840.1.113883.10.12.320 | CDA Subject (Body) | 2005‑09‑07 | cdaentrylevel
2.16.840.1.113883.10.12.321 | CDA Participant (Body) | 2005‑09‑07 | cdaentrylevel
2.16.840.1.113883.10.12.322 | CDA Specimen | 2005‑09‑07 | cdaentrylevel
2.16.840.1.113883.10.12.323 | CDA Performer (Body) | 2005‑09‑07 | cdaentrylevel
2.16.840.1.113883.10.12.324 | CDA Reference | 2005‑09‑07 | cdaentrylevel
2.16.840.1.113883.10.12.325 | CDA ExternalAct | 2005‑09‑07 | cdaentrylevel
2.16.840.1.113883.10.12.326 | CDA ExternalObservation | 2005‑09‑07 | cdaentrylevel
2.16.840.1.113883.10.12.327 | CDA ExternalProcedure | 2005‑09‑07 | cdaentrylevel
2.16.840.1.113883.10.12.328 | CDA ExternalDocument | 2005‑09‑07 | cdaentrylevel
2.16.840.1.113883.10.12.329 | CDA Precondition | 2005‑09‑07 | cdaentrylevel

## List of Value Set Identifiers used in this project

Id | Display Name | Effective date
--- | --- | ---
2.16.840.1.113883.1.11.13955 | ActEncounterCode | 2017‑12‑17
2.16.840.1.113883.1.11.16866 | ActPriority | 2014‑03‑26
2.16.840.1.113883.1.11.15933 | ActStatus | 2014‑03‑26
2.16.840.1.113883.1.11.20025 | ActStatusCompleted | 2014‑03‑26
2.16.756.5.30.1.1.11.81 | ActSubstanceAdminSubstitutionCode | 2020‑07‑10 00:52:42
2.16.840.1.113883.1.11.19708 | ActSubstanceAdministrationCode | 2014‑03‑26
2.16.756.5.30.1.1.11.82 | ActivePharmaceuticalIngredient | 2023‑10‑27 13:24:37
2.16.840.1.113883.1.11.14570 | AdministrableDrugForm | 2014‑03‑26
2.16.840.1.113883.1.11.1 | AdministrativeGender | 2014‑03‑26
2.16.840.1.113883.1.11.14832 | ApplicationMediaType | 2014‑03‑26
2.16.840.1.113883.1.11.14835 | AudioMediaType | 2014‑03‑26
2.16.756.5.30.1.127.77.4.11.2 | TimingEvent | 2020‑07‑10 00:28:08
2.16.756.5.30.1.127.77.4.11.7 | DispenseSupplyType | 2017‑01‑10 20:44:24
2.16.756.5.30.1.127.3.10.1.5 | DocumentEntry.confidentialityCode | 2022‑11‑29 13:34:05
2.16.756.5.30.1.127.3.10.1.27 | DocumentEntry.typeCode | 2023‑06‑08 14:45:10
2.16.840.1.113883.1.11.10871 | DocumentSectionType | 2018‑08‑12
2.16.840.1.113883.1.11.16040 | EntityCode | 2014‑03‑26
1.3.6.1.4.1.19376.1.5.3.1.11.3 | HealthStatus_value | 2016‑09‑26 14:09:34
2.16.840.1.113883.1.11.11526 | HumanLanguage | 2014‑03‑26
2.16.756.5.30.1.1.11.4 | IHE Pharmaceutical Advice Status List | 2023‑01‑26 10:55:04
2.16.756.5.30.1.1.11.77 | IHERoleCode Employer and School Contacts | 2016‑11‑11
2.16.840.1.113883.1.11.14839 | ImageMediaType | 2014‑03‑26
2.16.840.1.113883.1.11.12249 | LanguageAbilityMode | 2014‑03‑26
2.16.840.1.113883.1.11.12199 | LanguageAbilityProficiency | 2014‑03‑26
2.16.840.1.113883.1.11.12212 | MaritalStatus | 2014‑03‑26
2.16.840.1.113883.1.11.16041 | MaterialEntityClassType | 2014‑03‑26
2.16.756.5.30.1.1.11.85 | MedicationDosageQualifier | 2022‑02‑25 13:26:58
2.16.840.1.113883.1.11.14848 | ModelMediaType | 2014‑03‑26
2.16.840.1.113883.1.11.14850 | MultipartMediaType | 2014‑03‑26
2.16.840.1.113883.1.11.78 | ObservationInterpretation | 2017‑12‑17
2.16.840.1.113883.1.11.14079 | ObservationMethod | 2014‑03‑26
2.16.840.1.113883.1.11.16226 | ObservationType | 2017‑12‑17
2.16.756.5.30.1.127.77.4.11.4 | ProblemType | 2016‑07‑12 21:49:34
2.16.840.1.113883.1.11.10267 | ParticipationFunction | 2014‑03‑26
2.16.840.1.113883.1.11.16543 | ParticipationMode | 2014‑03‑26
2.16.840.1.113883.1.11.10282 | ParticipationSignature | 2014‑03‑26
2.16.840.1.113883.1.11.10901 | ParticipationType | 2014‑03‑26
2.16.840.1.113883.1.11.19563 | PersonalRelationshipRoleType | 2014‑03‑26
2.16.756.5.30.1.1.11.3 | Pharmaceutical Dose Form (EDQM) | 2024‑01‑30 14:03:36
1.3.6.1.4.1.19376.1.5.3.1.11.2 | ProblemStatusObservation_value | 2016‑09‑26 13:58:58
2.16.840.1.113883.1.11.16117 | ROIOverlayShape | 2014‑03‑26
cdachemed-valueset-3 | RegularUnitCode (Ambu) | 2022‑04‑15 09:05:07
2.16.840.1.113883.1.11.19316 | RoleClassMutualRelationship | 2014‑03‑26
2.16.840.1.113883.1.11.15999 | RoleStatus | 2014‑03‑26
2.16.840.1.113883.1.11.14581 | RouteOfAdministration | 2014‑03‑26
cdachemed-valueset-1 | RouteOfAdministration (Ambu) | 2022‑04‑15 08:51:35
2.16.756.5.30.1.1.11.2 | RouteOfAdministration (EDQM) | 2026‑02‑03 07:48:02
2.16.840.1.113883.1.11.17660 | ServiceDeliveryLocationRoleType | 2014‑03‑26
2.16.840.1.113883.1.11.10310 | TargetAwareness | 2014‑03‑26
2.16.840.1.113883.1.11.14825 | TextMediaType | 2014‑03‑26
cdachemed-valueset-4 | TimeUnitCode (Ambu) | 2022‑04‑15 09:05:42
cdachemed-valueset-2 | TimingEvent (Ambu) | 2022‑04‑15 09:00:03
2.16.756.5.30.1.1.11.83 | UnitCode | 2024‑03‑26 15:58:51
2.16.840.1.113883.1.11.14845 | VideoMediaType | 2014‑03‑26
2.16.840.1.113883.1.11.19599 | x_ActClassDocumentEntryAct | 2016‑11‑26
2.16.840.1.113883.1.11.19598 | x_ActClassDocumentEntryOrganizer | 2014‑03‑26
2.16.840.1.113883.1.11.18943 | x_ActMoodDocumentObservation | 2016‑11‑26
2.16.840.1.113883.1.11.19446 | x_ActRelationshipEntry | 2014‑03‑26
2.16.840.1.113883.1.11.19447 | x_ActRelationshipEntryRelationship | 2014‑03‑26
2.16.840.1.113883.1.11.19000 | x_ActRelationshipExternalReference | 2014‑03‑26
2.16.840.1.113883.1.11.16926 | x_BasicConfidentialityKind | 2014‑03‑26
2.16.840.1.113883.1.11.19458 | x_DocumentActMood | 2016‑11‑26
2.16.840.1.113883.1.11.19459 | x_DocumentEncounterMood | 2016‑11‑26
2.16.840.1.113883.1.11.19460 | x_DocumentProcedureMood | 2014‑03‑26
2.16.840.1.113883.1.11.19368 | x_DocumentSubject | 2014‑03‑26
2.16.840.1.113883.1.11.19461 | x_DocumentSubstanceMood | 2016‑11‑26
2.16.840.1.113883.1.11.19600 | x_EncounterParticipant | 2014‑03‑26
2.16.840.1.113883.1.11.19366 | x_InformationRecipient | 2014‑03‑26

Datasets, codes, OIDs and Rules: this information is used for rendering and validation purposes.